Pharmagen, Inc.
PHRX
$0.00
$0.000.00%
OTC PK
| 03/31/2014 | 12/31/2013 | 09/30/2013 | 06/30/2013 | 03/31/2013 | |
|---|---|---|---|---|---|
| Net Income | -79.57% | -116.53% | -148.55% | -340.67% | -433.57% |
| Total Depreciation and Amortization | 171.15% | 201.82% | 106.74% | 56.94% | 8.20% |
| Total Amortization of Deferred Charges | 115.70% | 323.80% | 1,222.36% | 1,154.54% | 9,753.78% |
| Total Other Non-Cash Items | 387.03% | 2,403.37% | -115.68% | 7,269.39% | -270.91% |
| Change in Net Operating Assets | 464.18% | 22,883.78% | 356.63% | 194.99% | 239.42% |
| Cash from Operations | 75.46% | 68.28% | 17.31% | 38.79% | -197.60% |
| Capital Expenditure | 3.02% | 39.62% | 64.05% | 0.47% | -96.29% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 44.78% | 67.40% | -24.45% | -123.57% | -244.71% |
| Total Debt Issued | -93.12% | -71.96% | 6.04% | -3.17% | 299.72% |
| Total Debt Repaid | -283.45% | -254.23% | -- | -11,068.97% | -184.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | -- | -- | -- | -- |
| Cash from Financing | -92.63% | -75.29% | -7.95% | -21.73% | 297.92% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -163.00% | -134.03% | 1,098.33% | 551.72% | 2,922.33% |